Product
Sublingual Tablet
2 clinical trials
3 indications
Indication
InsomniaIndication
Cancer PainIndication
Breakthrough PainClinical trial
National, Multicenter, Open, Single-arm, Phase III Clinical Trial to Evaluate the Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia.Status: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement Versus Intravenous PCA for Breakthrough Cancer Pain: A Prospective, Randomized, Open Label, Non Inferiority TrialStatus: Withdrawn, Estimated PCD: 2023-05-31